Cargando…
Effectiveness of trastuzumab as adjuvant therapy in patients with early stage breast cancer: A systematic review and meta-analysis
Background: Trastuzumab in combination with chemotherapy has long been established as a standard treatment for HER2-positive patients in early stage breast cancer (BC). The present study aimed at assessing the effectiveness of trastuzumab adjuvant therapy in early stage BC in overall survival (OS) a...
Autores principales: | Davari, Majid, Amani, Bahman, Mokarian, Fariborz, Hoseini, Mohsen, Akbarzadeh, Arash, Heidarzadeh Khoramabadi, Nastaran |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Iran University of Medical Sciences
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6014767/ https://www.ncbi.nlm.nih.gov/pubmed/29951389 http://dx.doi.org/10.14196/mjiri.31.88 |
Ejemplares similares
-
The Performance of the Nottingham Prognosis Index and the Adjuvant Online Decision Making Tool for Prognosis in Early-stage Breast Cancer Patients
por: Rejali, Mehri, et al.
Publicado: (2015) -
Pregabalin and gabapentin in neuropathic pain management after spinal cord injury: a systematic review and meta-analysis
por: Davari, Majid, et al.
Publicado: (2020) -
Adjuvant trastuzumab and vinorelbine for early-stage HER2+ breast cancer
por: McLaughlin, Shannon, et al.
Publicado: (2023) -
Deescalating Adjuvant Trastuzumab in HER2-Positive Early-Stage Breast Cancer: A Systemic Review and Meta-Analysis
por: Goldvaser, Hadar, et al.
Publicado: (2019) -
Adjuvant trastuzumab regimen for HER2-positive early-stage breast cancer: a systematic review and meta-analysis
por: Genuino, Anne Julienne, et al.
Publicado: (2019)